-
FTC Settlement With Cigna's Pharmacy Benefit Manager Promises Cheaper Insulin, Boosts Dividend On Strong Quarterly Earnings
Thursday, February 5, 2026 - 1:49pm | 762Read More...The Federal Trade Commission on Wednesday finalized a major settlement with Cigna Group’s (NYSE:CI) pharmacy benefit manager Express Scripts, aimed at dismantling anticompetitive practices that have historically inflated the cost of medications. • Cigna Group shares are climbing with...
-
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'
Friday, June 20, 2025 - 5:59am | 1111Read More...A heated debate over the U.S. healthcare system erupted on X, pitting billionaire entrepreneur Mark Cuban against Sen. Elizabeth Warren (D-Mass) over the root causes of soaring drug prices. What Happened: The clash, unfolding as of Friday, has reignited discussions on Pharmacy Benefit Managers (...
-
Mark Cuban Floats Bold Healthcare Plan: 'Zero Premiums To Insurance Companies' With A Cash-Pay Revolution
Tuesday, June 17, 2025 - 7:21am | 892Read More...Billionaire entrepreneur Mark Cuban has proposed a bold plan to revolutionize the U.S. healthcare system, eliminating traditional insurance premiums and introducing transparent pricing. What Happened: Cuban’s recent proposal, posted on social media platform X, comes amid growing frustration...
-
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion
Monday, May 19, 2025 - 3:50am | 1160Read More...After Donald Trump signed an executive order slashing drug prices last week, experts have highlighted how pharmacy benefit managers (PBMs) could be hit the hardest despite pharmaceutical companies facing the potential of compressed margins amid poor pricing power. What Happened: According to Thomas...
-
UnitedHealth Group Q4 Earnings Preview: First Report Since Insurance CEO's Murder Comes With Questions On Company's Future
Wednesday, January 15, 2025 - 4:55pm | 966Read More...Investors and analysts could turn attention to how UnitedHealth Group (NYSE:UNH) will replace its insurance unit CEO Brian Thompson, who was fatally shot in December, and how the company will keep public trust as the sector comes under increased scrutiny when the company reports fourth-quarter...
-
Bipartisan Lawmakers Aim To Break Up Health Care Giants With New Legislation
Wednesday, December 11, 2024 - 7:09pm | 495Read More...Pharmacy-benefit managers (PBMs) have been scrutinized for their role in drug distribution for years. Now a bipartisan group of lawmakers is threatening to break up the companies behind these so-called drug middlemen. What To Know: According to a Wall Street Journal report, Sen. Elizabeth Warren (D...
-
How You Can Use Mark Cuban's New Website To Get Cheaper Drugs
Monday, January 24, 2022 - 11:34am | 378Read More...Last week, billionaire and Dallas Mavericks owner Mark Cuban launched a new website that offers generic pharmaceutical drugs at a cheaper price than what’s available at most pharmacies. The company is called the Mark Cuban Cost Plus Drug Company (MCCPDC). MCCPDC will compete with pharmacy...
-
Trump Administration Withdraws Drug Rebate Plan
Thursday, July 11, 2019 - 8:58am | 429Read More...The Trump administration will no longer proceed with a large-scale overhaul of the drug-rebate industry. What Happened Pharmacy benefit managers (PBMs) negotiate a drug discount on behalf of health insurers and collect a commission for themselves as profit. Critics of the system argued it gives...
-
Analysts React To Diplomat Pharmacy's Q4 Earnings, Concerning Guidance
Monday, March 18, 2019 - 3:18pm | 530Read More...Diplomat Pharmacy Inc (NYSE: DPLO) on Friday reported its previously delayed fourth-quarter earnings miss and concerning guidance, which sent the stock tumbling nearly 14 percent. The Analysts Mizuho Securities' Ann Hynes maintains a Neutral rating on Diplomat Pharmacy with a price target...
-
Rite Aid Restructuring: CEO, CFO Out Along With 400 Full-Time Jobs
Wednesday, March 13, 2019 - 9:29am | 421Read More...Struggling drugstore Rite Aid Corporation (NYSE: RAD) announced Tuesday afternoon an organizational restructuring and leadership change which prompted a lift in stock price. What Happened Rite Aid said it will take action to reduce managerial layers and consolidate roles across the company. This...
-
CVS And Walmart Extend PBM, Managed Medicaid Agreement
Friday, January 18, 2019 - 10:25am | 337Read More...Walmart Inc (NYSE: WMT) announced Friday a multi-year agreement to remain in the CVS Health Corp (NYSE: CVS) Caremark pharmacy benefit management program and Managed Medicaid retail pharmacy network. The extension ensures ongoing engagement between the companies, who maintain other agreements...
-
Amazon's PillPack Acquisition: What It Means For The Tech Giant And Everybody Else
Friday, June 29, 2018 - 12:43pm | 951Read More...Amazon.com, Inc. (NASDAQ: AMZN) announced its acquisition of PillPack, an online pharmacy previously targeted by Walmart Inc (NYSE: WMT). The transaction is seen to advance Amazon’s health care campaign to the detriment of the vast and diverse sector. What It Means For Amazon Amazon had...
-
3 Ways Amazon Could Transform Health Care
Tuesday, May 15, 2018 - 11:22am | 363Read More...Amazon.com, Inc. (NASDAQ: AMZN) was reported last week to be building out a health and wellness team within its Alexa division to better integrate the assistant in health care. Loup Ventures considers this program just the start of a broader, three-pronged invasion of the $3.3 trillion industry....
-
Why Bernstein is Skeptical Of Cigna's Move to Buy Express Scripts
Tuesday, March 13, 2018 - 11:44am | 435Read More...Health insurer CIGNA Corporation (NYSE: CI) announced a deal March 8 to buy Express Scripts Holding Company (NASDAQ: ESRX) for $67 billion. The Analyst Bernstein analyst Lance Wilkes initiated coverage of Cigna with a Market Perform rating and $194 price target, suggesting 13-percent...
-
Predicted Gross Margin Pressure, EPS Erosion Turn Bernstein Bearish On Express Scripts
Thursday, February 1, 2018 - 2:05pm | 422Read More...Shares of Express Scripts Holding Company (NASDAQ: ESRX) have risen more than 30 percent since Thanksgiving 2017, mostly due to expectations of earnings improvements stemming from U.S. tax legislation. But the gains are now "overdone," according to Bernstein. The Analyst Bernstein...
















